| Literature DB >> 26822934 |
Miki Shimbo1, Takashi Kudo, Michito Hamada, Hyojung Jeon, Yuki Imamura, Keigo Asano, Risa Okada, Yuki Tsunakawa, Seiya Mizuno, Ken-Ichi Yagami, Chihiro Ishikawa, Haiyan Li, Takashi Shiga, Junji Ishida, Juri Hamada, Kazuya Murata, Tomohiro Ishimaru, Misuzu Hashimoto, Akiyoshi Fukamizu, Mutsumi Yamane, Masahito Ikawa, Hironobu Morita, Masahiro Shinohara, Hiroshi Asahara, Taishin Akiyama, Nobuko Akiyama, Hiroki Sasanuma, Nobuaki Yoshida, Rui Zhou, Ying-Ying Wang, Taito Ito, Yuko Kokubu, Taka-Aki K Noguchi, Hisako Ishimine, Akira Kurisaki, Dai Shiba, Hiroyasu Mizuno, Masaki Shirakawa, Naoki Ito, Shin Takeda, Satoru Takahashi.
Abstract
The Japan Aerospace Exploration Agency developed the mouse Habitat Cage Unit (HCU) for installation in the Cell Biology Experiment Facility (CBEF) onboard the Japanese Experimental Module ("Kibo") on the International Space Station. The CBEF provides "space-based controls" by generating artificial gravity in the HCU through a centrifuge, enabling a comparison of the biological consequences of microgravity and artificial gravity of 1 g on mice housed in space. Therefore, prior to the space experiment, a ground-based study to validate the habitability of the HCU is necessary to conduct space experiments using the HCU in the CBEF. Here, we investigated the ground-based effect of a 32-day housing period in the HCU breadboard model on male mice in comparison with the control cage mice. Morphology of skeletal muscle, the thymus, heart, and kidney, and the sperm function showed no critical abnormalities between the control mice and HCU mice. Slight but significant changes caused by the HCU itself were observed, including decreased body weight, increased weights of the thymus and gastrocnemius, reduced thickness of cortical bone of the femur, and several gene expressions from 11 tissues. Results suggest that the HCU provides acceptable conditions for mouse phenotypic analysis using CBEF in space, as long as its characteristic features are considered. Thus, the HCU is a feasible device for future space experiments.Entities:
Mesh:
Year: 2016 PMID: 26822934 PMCID: PMC4873486 DOI: 10.1538/expanim.15-0077
Source DB: PubMed Journal: Exp Anim ISSN: 0007-5124
Comparison of major features of cages in this study
Fig. 1.Mice housed in the Habitat Cage Unit (HCU) for 32 days
(A, B) Appearance of the HCU. (C) Inside the HCU. (D) Special food bars in the feeder cartridge. (E) A mouse in the HCU cage. (F) Body weight after housing in the control cage (Inocage) and the HCU for 32 days. (G) Water consumption data. (H) Food consumption data. (I) Measured duration for which mice could maintain themselves on the rotarod in both the control and HCU groups. The testing mice were placed on the rotarod two times, with retention times being averaged. Rotation speed increased from 2 to 40 rpm in 2 min. All data in Figure 1 are represented as means ± SEM. Control; n=6, HCU; n=6. Open bars indicate the control group. Closed bars indicate the HCU group. Asterisks denote P<0.01.
Fig. 2.Organ morphological characterization by immunohistochemical analysis
Thymic frozen sections were immunostained with a combination of anti-keratin-5 (red) and anti-keratin-8 (green) antibodies. Scale bar, 100 µm. Representative immunofluorescence images of the heart sections were stained with Phalloidin (red; F-actin), Connexin43 (green; gap junction), and nuclear stain Hoechst (blue). Scale bar, 100 µm. Kidney sections were stained with nephrin (red; podocytes in glomerulus), CD34 (green; endothelial cells), and nuclear stain Hoechst (blue). Scale bar, 100 µm.
Fig. 3.Characterization of hindlimb skeletal muscles
(A) Weights of five hindlimb muscles from C57BL/6J mice housed in control cages and the HCU are normalized to body weight. Soleus (Sol), plantaris (Pla), gastrocnemius (Gas), tibialis anterior (TA), and extensor digitorum longus (EDL). (B) Immunohistochemical staining for myosin heavy chains using BA-D5 (Type I), SC-71 (Type IIA), and BF-F3 (Type IIB) antibodies, and co-stained with anit-laminin-α2 antibody. Bar, 100 µm. (C) Percentage of respective fiber types in Gas. Immunoreactive fibers were counted and then calculated as a percentage of the total number of fibers based on the results of (B). (D) Distribution of the cross-sectional areas (CSAs) of gastrocnemius muscle fibers in the control and HCU groups plotted as frequency histograms. (E) Expression analysis of genes controlling muscle mass in hindlimb muscles using real-time PCR. The expression levels of each transcript were normalized to that of the Tbp (TATA box binding protein) transcript. All data in Fig. 3 are represented as means ± SEM. Control; n=6, HCU; n=6. Open bars indicate the control group. Closed bars indicate the HCU group.
Fig. 4.MicroCT analysis of the femur
The bone volume and structures of the femur were analyzed and quantified. BV/TV: bone volume/tissue volume in trabecular bone; BS/BV: bone surface/bone volume in trabecular bone; Tb.Th: trabecular bone thickness; Tb.N: trabecular bone number; Tb.Sp: trabecular separation; BMC/TV: bone mineral content/tissue volume; C.Th: cortical bone thickness; C.Sa: cortical bone sectional area; ELL: external line length of cortical bone; ILL: internal line length of cortical bone.
Fig. 5.Cauda epididymal sperm motility
Percentage of spermatozoa motility and average path velocity (VAP) in the control mice and HCU mice at 10 and 120 min. after thawing. Data are represented as means ± SD. Control; n=6, HCU; n=6. Open bars indicate the control group. Closed bars indicate the HCU group.
Quantitative analysis of gene expression
| Gene symbol | Description | Fold-change (SEM) |
|---|---|---|
| <Amygdala> | ||
| BDNF, Brain derived neurotrophic factor | 1.26 (0.49) | |
| <Striatum> | ||
| Gutamate receptor, ionotropic, AMPA1 (alpha 1) | 1.31 (0.22) | |
| <Cerebellar vermis> | ||
| Gutamate receptor, ionotropic, AMPA1 (alpha 1) | 1.13 (0.17) | |
| <Pituitary gland> | ||
| Follicle stimulating hormone, beta | 1.43 (0.13) | |
| Growth hormone | 0.92 (0.03) | |
| Luteinizing hormone beta polypeptide | 0.74 (0.11) | |
| Pro-opiomelanocortin-alpha (ACTH) | 1.04 (0.56) | |
| Thyroid stimulating hormone, beta | 0.91 (0.17) | |
| <Adrenal gland> | ||
| Cytochrome P450, family 11, subfamily a, polypeptide 1 | 0.90 (0.03) | |
| Cytochrome P450, family 11, subfamily B, polypeptide 2 | 0.85 (0.04) | |
| Cytochrome P450, family 17, subfamily a, polypeptide 1 | 0.87 (0.18) | |
| Cytochrome P450, family 21, subfamily a, polypeptide 1 | 0.82 (0.04) | |
| Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | 0.84 (0.06) | |
| <Thyroid gland> | ||
| Calcitonin-related polypeptide alpha | 1.52 (0.10)* | |
| Thyroglobulin | 1.20 (0.14) | |
| <BAT> | ||
| Cell death-inducing DFFA-like effector a | 0.78 (0.16) | |
| Deiodinase, iodothyronine, type II | 0.20 (0.03)* | |
| Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.45 (0.07)* | |
| Uncoupling 1 | 0.45 (0.06)* | |
| Uncoupling 2 | 0.84 (0.05) | |
| <WAT> | ||
| Adiponectin | 1.06 (0.10) | |
| Leptin | 0.61 (0.06) | |
| Retinol binding protein 4, plasma | 1.00 (0.07) | |
| Resistin | 0.93 (0.13) | |
| <Heart> | ||
| Peroxisome proliferative activated receptor, gamma, coactivator 1 alpha | 0.60 (0.08) | |
| Myosin, heavy polypeptide 6, cardiac muscle, alpha | 0.60 (0.05) | |
| Myosin, heavy polypeptide 7, cardiac muscle, beta | 0.87 (0.19) | |
| Troponin I, cardiac 3 | 1.13 (0.04) | |
| Desmin | 1.04 (0.11) | |
| Collagen, type I, alpha 1 | 0.83 (0.07) | |
| Natriuretic peptide type A | 1.01 (0.22) | |
| Natriuretic peptide type B | 4.30 (1.21) | |
| ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 | 0.73 (0.06) | |
| F-box protein 32 | 0.71 (0.07) | |
| Tripartite motif-containing 63 | 0.61 (0.08) | |
| Beclin 1, autophagy related | 0.69 (0.13) | |
| Gamma-aminobutyric acid A receptor-associated protein-like 1 | 0.87 (0.15) | |
| <Kidney> | ||
| Chemokine (C-C motif) ligand 2 | 4.37 (0.69) | |
| Interleukin 1 beta | 2.16 (0.68) | |
| Interleukin 6 | 1.16 (0.07) | |
| Tumor necrosis factor | 0.85 (0.05) | |
| Transforming growth factor, beta 1 | 0.94 (0.10) | |
| Collagen, type I, alpha 1 | 0.91 (0.26) | |
| Tissue inhibitor of metalloproteinase 1 | 1.00 (0.08) | |
| Vascular cell adhesion molecule 1 | 1.34 (0.21) | |
| Intercellular adhesion molecule 1 | 1.18 (0.21) | |
| Sodium channel, nonvoltage-gated 1 alpha | 1.40 (0.16) | |
| Lipocalin 2 | 1.05 (0.04) | |
| Nephrosis 2 | 2.06 (0.38) | |
| Nephrosis 1 | 1.32 (0.19) | |
| Tight junction protein 1 | 1.32 (0.31) | |
Fold-change relative to control, Asterisks denote P<0.05.